Chemical and Pharmaceutical Bulletin · 2004 · 13 citations · 15 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryStructure-activity RelationshipsHit-to-lead OptimizationLead Compound DesignLead DiscoveryPotency OptimizationQuantitative Structure-activity RelationshipsStructure-activity Relationship AnalysisChemical ModificationChemical Synthesis Of AnaloguesLead Compound IdentificationPharmacological PotencyPharmacological ScreeningPhosphodiesterase InhibitionPhosphodiesterase-4 InhibitorsStructure-based Lead Discovery
A series of 4-anilinopyrazolopyridine derivatives were synthesized and biologically evaluated as inhibitors of phosphodiesterase (PDE4). Chemical modification of 3, a structurally new chemical lead that was found in our in-house library, was focused on 1- and 3-substituents. Full details of the discovery of a new orally active chemical lead 5 are presented. Structure-activity relationship data, pharmacological evaluation, and the subtype selectivity study are also presented.
15
M. L. REEVES, B. K. Leigh, P. England · Biochemical Journal · 1987 · 304 citations · Full text
Theodore J. Torphy, Han-liang Zhou, L B Cieslinski · Journal of Pharmacology and Experimental Therapeutics · 1992 · 124 citations